Tsutomu Shimura1, Naoto Noma2, Yui Sano2, Yasushi Ochiai2, Toshiyuki Oikawa2, Manabu Fukumoto2, Naoki Kunugita3. 1. Department of Environmental Health, National Institute of Public Health, Japan. Electronic address: tsimura@niph.go.jp. 2. Department of Pathology, Institute of Development, Aging and Cancer, Tohoku University, Japan. 3. Department of Environmental Health, National Institute of Public Health, Japan.
Abstract
BACKGROUND AND PURPOSE: Cellular radioresistance is a major impediment to effective radiotherapy. Here, we demonstrated that long-term exposure to fractionated radiation conferred acquired radioresistance to tumor cells due to AKT-mediated enhanced aerobic glycolysis. MATERIAL AND METHODS: Two human tumor cell lines with acquired radioresistance were established by long-term exposure to fractionated radiation with 0.5 Gy of X-rays. Glucose uptake was inhibited using 2-deoxy-D-glucose, a non-metabolizable glucose analog. Aerobic glycolysis was assessed by measuring lactate concentrations. Cells were then used for assays of ROS generation, survival, and cell death as assessed by annexin V staining. RESULTS: Enhanced aerobic glycolysis was shown by increased glucose transporter Glut1 expression and a high lactate production rate in acquired radioresistant cells compared with parental cells. Inhibiting the AKT pathway using the AKT inhibitor API-2 abrogated these phenomena. Moreover, we found that inhibiting glycolysis with 2-deoxy-D-glucose suppressed acquired tumor cell radioresistance. CONCLUSIONS: Long-term fractionated radiation confers acquired radioresistance to tumor cells by AKT-mediated alterations in their glucose metabolic pathway. Thus, tumor cell metabolic pathway is an attractive target to eliminate radioresistant cells and improve radiotherapy efficacy.
BACKGROUND AND PURPOSE: Cellular radioresistance is a major impediment to effective radiotherapy. Here, we demonstrated that long-term exposure to fractionated radiation conferred acquired radioresistance to tumor cells due to AKT-mediated enhanced aerobic glycolysis. MATERIAL AND METHODS: Two humantumor cell lines with acquired radioresistance were established by long-term exposure to fractionated radiation with 0.5 Gy of X-rays. Glucose uptake was inhibited using 2-deoxy-D-glucose, a non-metabolizable glucose analog. Aerobic glycolysis was assessed by measuring lactate concentrations. Cells were then used for assays of ROS generation, survival, and cell death as assessed by annexin V staining. RESULTS: Enhanced aerobic glycolysis was shown by increased glucose transporter Glut1 expression and a high lactate production rate in acquired radioresistant cells compared with parental cells. Inhibiting the AKT pathway using the AKT inhibitor API-2 abrogated these phenomena. Moreover, we found that inhibiting glycolysis with 2-deoxy-D-glucose suppressed acquired tumor cell radioresistance. CONCLUSIONS: Long-term fractionated radiation confers acquired radioresistance to tumor cells by AKT-mediated alterations in their glucose metabolic pathway. Thus, tumor cell metabolic pathway is an attractive target to eliminate radioresistant cells and improve radiotherapy efficacy.
Authors: B Farhood; N H Goradel; K Mortezaee; N Khanlarkhani; E Salehi; M S Nashtaei; H Mirtavoos-Mahyari; E Motevaseli; D Shabeeb; A E Musa; M Najafi Journal: Clin Transl Oncol Date: 2018-08-22 Impact factor: 3.405
Authors: Lei Chang; Peter Graham; Jingli Hao; Jie Ni; Junli Deng; Joseph Bucci; David Malouf; David Gillatt; Yong Li Journal: Oncotarget Date: 2016-03-08
Authors: Apostolos Menegakis; Rob Klompmaker; Claire Vennin; Aina Arbusà; Maartje Damen; Bram van den Broek; Daniel Zips; Jacco van Rheenen; Lenno Krenning; René H Medema Journal: Cells Date: 2021-03-10 Impact factor: 6.600
Authors: Ana T Pinto; Marta L Pinto; Sérgia Velho; Marta T Pinto; Ana P Cardoso; Rita Figueira; Armanda Monteiro; Margarida Marques; Raquel Seruca; Mário A Barbosa; Marc Mareel; Maria J Oliveira; Sónia Rocha Journal: PLoS One Date: 2016-08-11 Impact factor: 3.240